Brief: Impel Pharmaceuticals Inc Received Notice From Nasdaq That It Is No Longer Complies With Minimum Bid Price Requirement For Continued Listing
04/10/2023 23:05
Oct 4 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS INC: ON SEPT 28, CO RECEIVED NOTICE
FROM
NASDAQ, CO NO LONGER COMPLIES WITH MINIMUM BID PRICE REQUIREMENT
FOR CONTINUED LISTING
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq